Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
U.S. lawmakers and investors are turning attention to alleged Chinese access to U.S. AI models, with new disclosures ...
Six months into 2026, Ford faces a rare stumble as a Japanese competitor outsells its flagship F-Series in the period...
New market data challenge the idea that AI spending is peaking. AI infrastructure is expanding, with implications for...
When penguin stock popped today, investors asked: what changed in a single session? This article breaks down the cata...
Bitcoin trades near $62,000 as macro risks surge. A little-known BTC-Gold ratio signal is flashing, potentially forec...
A new ruling in a separate case from Judge Analisa Torres introduces fresh uncertainty for XRP. With the token around...
An official says Trump is not expected to veto the housing bill, signaling a potential policy path. Markets are weigh...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
Prices may look flat, but the real bill for home buying in 2026 is higher. This guide reveals where data lies, what b...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
SpaceX is growing fast, but its financing moves could change the risk profile for investors. This article breaks down...